diligent Anteater_54
liked
$NVIDIA(NVDA.US$ who is also stuck at 9xx 😭😭😭
5
2
$Evaxion Biotech(EVAX.US$ Evaxion Biotech beat estimated earnings by 90.0%, that's great news!!
diligent Anteater_54
voted
$Trump Media & Technology(DJT.US$ began trading under its new ticker on Tuesday, traditional media outlets could hardly understand the stock’s 50% rise. How could a loss-making firm in a cut-throat industry become worth almost $10 billion overnight?
Short sellers have also sensed blood. According to Fintel.io, a financial data provider, virtually all available DJT shares have been sold short. Borrowing fees currently stand at over 210%,...
Short sellers have also sensed blood. According to Fintel.io, a financial data provider, virtually all available DJT shares have been sold short. Borrowing fees currently stand at over 210%,...
23
14
diligent Anteater_54
voted
The winning miner 🚀
$Bitfarms(BITF.US$ $Marathon Digital(MARA.US$ $CleanSpark(CLSK.US$ $Riot Platforms(RIOT.US$ $Canaan(CAN.US$ $Coinbase(COIN.US$ $MicroStrategy(MSTR.US$ $ProShares Bitcoin Strategy ETF(BITO.US$ $ARK Innovation ETF(ARKK.US$ $Block(SQ.US$ $Bitcoin(BTC.CC$ $Ethereum(ETH.CC$ $Solana(SOL.CC$ $Tesla(TSLA.US$
$Bitfarms(BITF.US$ $Marathon Digital(MARA.US$ $CleanSpark(CLSK.US$ $Riot Platforms(RIOT.US$ $Canaan(CAN.US$ $Coinbase(COIN.US$ $MicroStrategy(MSTR.US$ $ProShares Bitcoin Strategy ETF(BITO.US$ $ARK Innovation ETF(ARKK.US$ $Block(SQ.US$ $Bitcoin(BTC.CC$ $Ethereum(ETH.CC$ $Solana(SOL.CC$ $Tesla(TSLA.US$
8
$Evaxion Biotech(EVAX.US$ Great R&D Day presentation this afternoon at Evaxion headquaters. Looks like 24-25 will be great years, and the possibilities with these AI models will most definitely break grounds and push up. 🙌
Story by George Maybach •
The average one-year price target for Evaxion Biotech A (NasdaqCM:EVAX) has been revised to 18.36 / share. This is an increase of 414.29% from the prior estimate of 3.57 dated January 16, 2024.
The price target is an average of many targets provided by analysts. The latest targets range from a low of 14.14 to a high of 21.00 / share. The average price target represents an increase of 392.23% from the latest reported cl...
The average one-year price target for Evaxion Biotech A (NasdaqCM:EVAX) has been revised to 18.36 / share. This is an increase of 414.29% from the prior estimate of 3.57 dated January 16, 2024.
The price target is an average of many targets provided by analysts. The latest targets range from a low of 14.14 to a high of 21.00 / share. The average price target represents an increase of 392.23% from the latest reported cl...
1
diligent Anteater_54
liked